News

In November, the company reported that it had received a question from the FDA regarding chemistry, manufacturing and controls (CMC) that has now been resolved. Preclinical studies of

Under the terms of agreement, GSK will obtain an exclusive license to commercialize IPX066 throughout the world, except in the US and Taiwan. Impax will receive an upfront

Catalyst and Wyeth LLC (the successor to Wyeth), a wholly owned subsidiary of Pfizer, formed an exclusive, worldwide collaboration for the discovery, development and commercialization of improved, second

CombiPlex is an approach using drug carriers (nano-scale liposomes) to deliver synergistic ratios of drug combinations for the treatment of cancer. Celator Pharma claims that in contrast to

Initial shipments of pre-mixed Sucanon from Canada have already commenced, totaling five (5) containers – the equivalent of 6,000,000 tablets or 100,000 one-month patient supplies. Fero Industries has

Brilinta is a direct-acting P2Y12 receptor antagonist in a chemical class called cyclopentyltriazolopyrimidines (CPTPs). In the CRL, the FDA requested additional analyses of the Plato data. Plato was

The BantamPro ELSP occupies similar floor space on the packaging line as manual operations and less floor space compared to disparate supplier pieces of equipment integrated in the

As part of the acquisition agreement, DSP will become a part of the Emerald Kalama Chemical business unit, which manufactures and markets products and technologies targeted to food

As per the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck. Under